<DOC>
	<DOC>NCT01055769</DOC>
	<brief_summary>The purpose of this study is to estimate the bioequivalence comparing Linezolid 600 MG Oral Suspension with 600 MG tablet in Chinese healthy male subjects. This study data will be used to support Linezolid OS NDA in China.</brief_summary>
	<brief_title>Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects</brief_title>
	<detailed_description>To support Linezolid NDA in China.</detailed_description>
	<mesh_term>Linezolid</mesh_term>
	<criteria>Healthy volunteers. 1840 years old, male. BMI 1924kg/m2. Alcohol, drug, smoke user. Sensitive to oxazolidinones antibiotics class drug or heparin. Severe medical or psychiatric condition or laboratory abnormality. Blood donation. 12ECG abnormal. Treatment with study drug; clinically significant.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Bio-equivalence</keyword>
	<keyword>Linezolid OS</keyword>
	<keyword>Linezolid tablet</keyword>
</DOC>